These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 38551099)
41. Rates of New Human Immunodeficiency Virus (HIV) Diagnoses After Reported Sexually Transmitted Infection in Women in Louisiana, 2000-2015: Implications for HIV Prevention. Newman DR; Rahman MM; Brantley A; Peterman TA Clin Infect Dis; 2020 Mar; 70(6):1115-1120. PubMed ID: 30976788 [TBL] [Abstract][Full Text] [Related]
42. Van Praet JT; Steyaert S; Vandecasteele S; Van Den Bergh B; Mahieu H; De Buyser S; Grootaert V; Descheemaeker P; Reynders M Sex Transm Infect; 2020 Sep; 96(6):396-398. PubMed ID: 31896737 [TBL] [Abstract][Full Text] [Related]
43. Discussion and Initiation of HIV Pre-exposure Prophylaxis Were Rare Following Diagnoses of Sexually Transmitted Infections Among Veterans. Kobayashi T; Van Epps P; Maier MM; Beste LA; Beck BF; Alexander B; Ohl ME J Gen Intern Med; 2022 Aug; 37(10):2482-2488. PubMed ID: 34341917 [TBL] [Abstract][Full Text] [Related]
44. Assessment for sexually transmitted infections in men who have sex with men attending a nurse-run HIV preexposure prophylaxis clinic. Stockton JM J Am Assoc Nurse Pract; 2021 Feb; 33(12):1290-1294. PubMed ID: 33625163 [TBL] [Abstract][Full Text] [Related]
45. Sexually Transmitted Infections on the Rise in PrEP Users. Barreiro P AIDS Rev; 2018; 20(1):71. PubMed ID: 29628512 [TBL] [Abstract][Full Text] [Related]
46. Incidence of Gonorrhea and Chlamydia Following Human Immunodeficiency Virus Preexposure Prophylaxis Among Men Who Have Sex With Men: A Modeling Study. Jenness SM; Weiss KM; Goodreau SM; Gift T; Chesson H; Hoover KW; Smith DK; Liu AY; Sullivan PS; Rosenberg ES Clin Infect Dis; 2017 Sep; 65(5):712-718. PubMed ID: 28505240 [TBL] [Abstract][Full Text] [Related]
47. Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV preexposure prophylaxis. Tang EC; Vittinghoff E; Philip SS; Doblecki-Lewis S; Bacon O; Chege W; Coleman ME; Elion R; Buchbinder S; Kolber MA; Liu AY; Cohen SE AIDS; 2020 Jul; 34(8):1181-1186. PubMed ID: 32205724 [TBL] [Abstract][Full Text] [Related]
48. Sexually transmitted infection screening, prevalence and incidence among South African men and transgender women who have sex with men enrolled in a combination HIV prevention cohort study: the Sibanye Methods for Prevention Packages Programme (MP3) project. Jones J; Sanchez TH; Dominguez K; Bekker LG; Phaswana-Mafuya N; Baral SD; McNaghten AD; Kgatitswe LB; Valencia R; Yah CS; Zahn R; Siegler AJ; Sullivan PS J Int AIDS Soc; 2020 Oct; 23 Suppl 6(Suppl 6):e25594. PubMed ID: 33000886 [TBL] [Abstract][Full Text] [Related]
49. Brief Report: Use of Remnant Specimens to Assess Use of HIV PrEP Among Populations With Risk of HIV Infection: A Novel Approach. Pathela P; Qasmieh S; Gandhi M; Rozen E; Okochi H; Goldstein H; Herold BC; Jamison K; Schillinger JA; Nash D J Acquir Immune Defic Syndr; 2022 Aug; 90(4):382-387. PubMed ID: 35357337 [TBL] [Abstract][Full Text] [Related]
50. Pre-exposure prophylaxis (PrEP) use trajectories and incidence of HIV and other sexually transmitted infections among PrEP users in Belgium: a cohort analysis of insurance claims data from 2017 to 2019. Rotsaert A; Smekens T; Jaminé D; Di Zinno T; Deblonde J; Lambert ML; Florence E; Reyniers T; Vanhamel J; Lucet C; van der Loeff MS; Hensen B; Vuylsteke B BMC Public Health; 2024 Aug; 24(1):2296. PubMed ID: 39179990 [TBL] [Abstract][Full Text] [Related]
51. [Evaluating the introduction of HIV pre-exposure prophylaxis as a benefit of statutory health insurance (EvE-PrEP) : Highly effective protection against HIV without an increase in sexually transmitted infections]. Schmidt D; Kollan C; Schewe K; Hanhoff N; Rüsenberg R; Friebe M; Schikowski T; Schink SB; Marcus U; Koppe U; Jansen K; Streeck H; Ottensmeyer P; An der Heiden M; Bannert N; M'Bayo R; Ceres M; Weber L; Sweers H; Schmidt AJ; Tietz H; Danan E; Bendig J; Kloep S; Neumann A; Valbert F; Wasem J; Bartmeyer B; Bremer V; Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Sep; 66(9):1008-1018. PubMed ID: 37436444 [TBL] [Abstract][Full Text] [Related]
52. Effect of rectal douching/enema on rectal gonorrhoea and chlamydia among a cohort of men who have sex with men on HIV pre-exposure prophylaxis. Hassan A; Blumenthal JS; Dube MP; Ellorin E; Corado K; Moore DJ; Morris SR Sex Transm Infect; 2018 Nov; 94(7):508-514. PubMed ID: 29907624 [TBL] [Abstract][Full Text] [Related]
53. Pre-exposure prophylaxis and bacterial sexually transmitted infections (STIs) among gay and bisexual men. Hart TA; Noor SW; Berlin GW; Skakoon-Sparling S; Tavangar F; Tan D; Lambert G; Grace D; Lachowsky NJ; Jollimore J; Sang J; Parlette A; Lal A; Apelian H; Moore D; Cox J; Sex Transm Infect; 2023 May; 99(3):167-172. PubMed ID: 35701145 [TBL] [Abstract][Full Text] [Related]
54. Evidence of changing sexual behaviours and clinical attendance patterns, alongside increasing diagnoses of STIs in MSM and TPSM. MacGregor L; Speare N; Nicholls J; Harryman L; Horwood J; Kesten JM; Lorenc A; Horner P; Edelman NL; Muir P; North P; Gompels M; Turner KME Sex Transm Infect; 2021 Nov; 97(7):507-513. PubMed ID: 34413201 [TBL] [Abstract][Full Text] [Related]
55. Reviewing PrEP's Effect on STI Incidence Among Men Who Have sex with Men-Balancing Increased STI Screening and Potential Behavioral Sexual Risk Compensation. Kumar S; Haderxhanaj LT; Spicknall IH AIDS Behav; 2021 Jun; 25(6):1810-1818. PubMed ID: 33242186 [TBL] [Abstract][Full Text] [Related]
56. Choosing event-driven and daily HIV pre-exposure prophylaxis - data from two European PrEP demonstration projects among men who have sex with men. Jongen VW; Reyniers T; Ypma ZM; Schim van der Loeff MF; Davidovich U; Zimmermann HM; Coyer L; van den Elshout MA; de Vries HJ; Wouters K; Smekens T; Vuylsteke B; Prins M; Laga M; Hoornenborg E J Int AIDS Soc; 2021 Aug; 24(8):e25768. PubMed ID: 34382345 [TBL] [Abstract][Full Text] [Related]
57. Latent Class Analysis of Sexual Behaviours and Attitudes to Sexually Transmitted Infections Among Gay and Bisexual Men Using PrEP. Traeger MW; Murphy D; Ryan KE; Asselin J; Cornelisse VJ; Wilkinson AL; Hellard ME; Wright EJ; Stoové MA AIDS Behav; 2022 Jun; 26(6):1808-1820. PubMed ID: 34782934 [TBL] [Abstract][Full Text] [Related]
58. Determining the screening frequency for sexually transmitted infections for people who use HIV pre-exposure prophylaxis: a systematic review and meta-analysis. Kim CM; Zhao V; Brito De Mello M; Baggaley R; Johnson CC; Spielman E; Fairley CK; Zhang L; de Vries H; Klausner J; Zhao R; Ong JJ Int J Infect Dis; 2023 Apr; 129():181-187. PubMed ID: 36690140 [TBL] [Abstract][Full Text] [Related]
59. Bacterial sexually transmitted infections are concentrated in subpopulations of men who have sex with men using HIV pre-exposure prophylaxis. Jongen VW; Van Der Loeff MFS; Van Den Elshout M; Wijstma E; Coyer L; Davidovich U; De Vries HJC; Prins M; Hoornenborg E; Boyd A AIDS; 2023 Nov; 37(13):2059-2068. PubMed ID: 37503635 [TBL] [Abstract][Full Text] [Related]
60. Doxycycline prophylaxis for the prevention of sexually transmitted infections: A systematic review and meta-analysis of randomized controlled trials. Szondy I; Meznerics FA; Lőrincz K; Kemény LV; Walter A; Mohammed AA; Hegyi P; Kiss N; Bánvölgyi A Int J Infect Dis; 2024 Oct; 147():107186. PubMed ID: 39122208 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]